-transparent.png){kind=logo}
Of 49 compounds known to have antitumor properties, 6 were found to have significant activity against Trypanosoma rhodesiense infections in mice. Activity against the African trypanosomes has not been reported previously for any of these six compounds. In order of decreasing activity these compounds were: (i) imidazole-4-carboxamide, 5-(3,3-dimethyl-1,1-triazene), (ii) inosine diglycolaldehyde, (iii) cis-diamminedichloro-platinum, (iv) streptozotocin, (v) coralyne sulfate, and (vi) 5-fluoro-2'-deoxyuridine. The percentage of "hits" (12.2%) from these known antitumor agents was approximately twice as great as when other means are employed for the selection of compounds for this test system.
K E Kinnamon, and
E A Steck, and
D S Rane
January 1977,
Nature,
K E Kinnamon, and
E A Steck, and
D S Rane
November 2018,
Antimicrobial agents and chemotherapy,
K E Kinnamon, and
E A Steck, and
D S Rane
January 2009,
Antimicrobial agents and chemotherapy,
K E Kinnamon, and
E A Steck, and
D S Rane
June 2004,
Natural product reports,
K E Kinnamon, and
E A Steck, and
D S Rane
April 1989,
Proceedings of the National Academy of Sciences of the United States of America,
K E Kinnamon, and
E A Steck, and
D S Rane
March 1995,
Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ),
K E Kinnamon, and
E A Steck, and
D S Rane
October 2009,
Current opinion in immunology,
K E Kinnamon, and
E A Steck, and
D S Rane
May 1993,
Parasitology today (Personal ed.),
K E Kinnamon, and
E A Steck, and
D S Rane
April 2006,
The Journal of parasitology,
K E Kinnamon, and
E A Steck, and
D S Rane
December 2016,
Parasite immunology,
